Latest News and Press Releases

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Conduit Pharmaceuticals Announces Leadership Changes

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects